Pharma Journalist -

SMi Reports: The Injectable Drug Delivery Conference returns to London on 13th and 14th May, 2020 SMi Group is delighted to announce the highly anticipated 3rd annual Injectable Drug…
Read More...

InxMed (Shanghai) Co., Ltd., a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced that the company has…
Read More...

ATAI Life Sciences AG announced that it has partnered with Neuronasal Inc., to develop a short-term treatment for mild Traumatic Brain Injury (mTBI) or concussion. Neuronasal's…
Read More...

Pulmatrix, Inc. a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases announced that it has entered into a research…
Read More...

SMi announce key highlights ahead of RNA Therapeutics 2020, including topics to be discussed and confirmed attendees. In less than 6 weeks, the doors will open to SMi's RNA…
Read More...

SMi has released an exclusive interview with industry expert Shikta Das, Independent Senior Data Scientist, ahead of the upcoming Disruptive Technologies in Pharma conference this…
Read More...

Abcam plc, a global innovator in life science reagents and tools, is pleased to announce the successful completion of the acquisition of Expedeon's Proteomics and Immunology business,…
Read More...

SMi Reports: Only 2 weeks left to register for Pre-Filled Syringes & Injectable Drug Devices 2020 Just 2 weeks remain until Europe's leading conference on Pre-Filled Syringes…
Read More...

Charles River Laboratories International announced that it has completed the previously announced acquisition of HemaCare Corporation for approximately $380 million in cash, or $25.40…
Read More...

Leap Therapeutics and BeiGene announced an exclusive option and license agreement for the clinical development and commercialization of DKN-01, Leap's anti-Dickkopf-1 (DKK1) antibody,…
Read More...